PATENT CLAIM ANALYSIS

Application Number: 16318209
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-09
Patent Classification: ["424", "001890"]

Abstract:
The present invention relates to radiolabeled IDO1 inhibitors or pharmaceutically acceptable salts thereof which are useful for the quantitative imaging of IDO enzymes in mammals.

Claim (Index 11):
A method for quantifying diseased cells or tissues in a subject, comprising\n (a) administering to a subject having diseased cells or tissues the radiolabeled compound of  claim 2  which binds to the IDO1 enzyme located within the diseased cells or tissues; and (b) detecting radioactive emissions of the radiolabeled compound in the diseased cells or tissues, wherein the level and distribution of the radioactive emissions in the diseased cells or tissues is a quantitative measure of the diseased cells or tissues.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 99.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15505214', '12154445', '15030214', '15316937', '15331446']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.706424141628155
- 35 USC 102 Novelty (BERT): 0.5071247896305733
- Combined Prediction Score: 0.6864942064283969
- Mean Citation Score: 219.596168
- Max Citation Score: 234.1491
- Similarity Product: 142.34052736963034

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test